Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations

Nav

General Info

Geography

United States of America (USA)

Time period covered

01/2000 - 12/2013

Data type

Scientific literature

Keywords

Congenital anomalies, Congenital heart anomalies

Citation

Authors

Bateman BT, Patorno E, Desai RJ, Seely EW, Mogun H, Dejene SZ, Fischer MA, Friedman AM, Hernandez-Diaz S, Huybrechts KF

Journal

Obstet Gynecol

Volume

129

Issue

Pages

174-184

Publication year

2017

Suggested citation

Bateman BT, Patorno E, Desai RJ, Seely EW, Mogun H, Dejene SZ, Fischer MA, Friedman AM, Hernandez-Diaz S, Huybrechts KF. Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations. Obstet Gynecol. 2017; 129(1): 174-184.

DOI

10.1097/AOG.0000000000001775

PMID

27926639

GHDx Entry last modified on: May 30, 2020

Header sites

Search form

Main menu

Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations

Nav